MYO TECHNOLOGY Trademark

Trademark Overview

On Monday, December 30, 2024, a trademark application was filed for MYO TECHNOLOGY with the United States Patent and Trademark Office. The USPTO has given the MYO TECHNOLOGY trademark a serial number of 98927863. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Tuesday, July 22, 2025. This trademark is owned by RENBIO, INC.. The MYO TECHNOLOGY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations containing nucleic acid sequences that encode monoclonal antibodies for the treatment of cancer, autoimmune diseases, rare diseases, infectious diseases, inflammatory diseases, and blood disorders; Pharmaceutical compositions for the prevention and treatment of cancer, autoimmune diseases, rare diseases, infectious diseases, inflammatory diseases, and blood disorders; Nucleic acid sequences for medical purposes; Pharmaceutical compositions, namely, a nucleotide sequence that encodes an antigen, such as a DNA plasmid having an antigen encoding sequence and like DNA, for the prevention and treatment of cancer, autoimmune diseases, rare diseases, infectious diseases, inflammatory diseases, and blood disorders; Pharmaceutical preparations for human use for the treatment and prevention of cancer, autoimmune diseases, rare diseases, infectious diseases, inflammatory diseases, and blood disorders; pharmaceutical preparations for human and veterinary use, namely, an...
myo technology

General Information

Serial Number98927863
Word MarkMYO TECHNOLOGY
Filing DateMonday, December 30, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateTuesday, July 22, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Description of MarkThe mark consists of the wording "MYO" on top of the wording "TECHNOLOGY". The "O" in "MYO" consists of a helix with a line down the middle, inside of a circle and a second outer circle.
Goods and ServicesPharmaceutical preparations containing nucleic acid sequences that encode monoclonal antibodies for the treatment of cancer, autoimmune diseases, rare diseases, infectious diseases, inflammatory diseases, and blood disorders; Pharmaceutical compositions for the prevention and treatment of cancer, autoimmune diseases, rare diseases, infectious diseases, inflammatory diseases, and blood disorders; Nucleic acid sequences for medical purposes; Pharmaceutical compositions, namely, a nucleotide sequence that encodes an antigen, such as a DNA plasmid having an antigen encoding sequence and like DNA, for the prevention and treatment of cancer, autoimmune diseases, rare diseases, infectious diseases, inflammatory diseases, and blood disorders; Pharmaceutical preparations for human use for the treatment and prevention of cancer, autoimmune diseases, rare diseases, infectious diseases, inflammatory diseases, and blood disorders; pharmaceutical preparations for human and veterinary use, namely, antibiotics, antifungals and anti-virals; Gene therapy and prophylactic products, namely, gene delivery pharmaceuticals for the treatment of genetic or cell based conditions.
Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"TECHNOLOGY"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 30, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRENBIO, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLong Island City, NY 11101

Trademark Events

Event DateEvent Description
Monday, December 30, 2024NEW APPLICATION ENTERED
Monday, June 2, 2025NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, June 2, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 22, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, July 22, 2025NON-FINAL ACTION WRITTEN
Tuesday, July 22, 2025NON-FINAL ACTION E-MAILED
Wednesday, June 11, 2025ASSIGNED TO EXAMINER

Related Keywords

technology diseases pharmaceutical cancer autoimmune rare infectious disorders inflammatory treatment blood